Patents by Inventor Jingyan Han

Jingyan Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING AND/OR TREATING ISCHEMIC REPERFUSION INJURY
    Publication number: 20210038668
    Abstract: The present invention discloses a traditional Chinese medicinal composition for preventing and/or treating ischemia reperfusion injury; the traditional Chinese medicinal composition consists of salvianolic acids, Panax notoginseng saponins and total saponins of Astragalus.
    Type: Application
    Filed: March 25, 2019
    Publication date: February 11, 2021
    Inventors: Jingyan HAN, Qingfang CHEN, Dandan HUANG, Xiaohui MA, Yi HE, Shuiping ZHOU
  • Use of Danshensu, Notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
    Patent number: 9101640
    Abstract: The present invention relates to a new use of traditional Chinese drug products of Danshensu (DLA), Notoginsenoside R1 (R1) and their combination, in particular to the therapeutic and preventive effects of DLA, R1 and their combination on the diseases caused by microcirculation disorder.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: August 11, 2015
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Jingyan Han, Jun Guo, Jiying Yang, Kai Sun, Mingxia Wang, Yu Zhang, Yuying Liu
  • Traditional Chinese drug comprising Danshen extracts and Sanqi extracts and use thereof
    Patent number: 9034398
    Abstract: The present invention discloses a traditional Chinese drug consisting of Danshen extract and Sanqi extract, the pharmaceutical composition comprising the above traditional Chinese drug as an active component and the use thereof. The traditional Chinese drug consists of Danshen extract and Sanqi extract in a weight ratio of (2˜6):(0.5˜2). The invention further discloses the effect of the above traditional Chinese drug and the pharmaceutical composition comprising the above traditional Chinese drug as an active component for treating cardiac microcirculation disorder and myocardial damage induced by ischemia/reperfusion.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: May 19, 2015
    Assignee: TASLY Pharmaceutical Group Co., LTD.
    Inventors: Jingyan Han, Jun Guo, Jiying Yang, Yu Zhang, Mingxia Wang, Yuying Liu
  • USE OF DANSHENSU, NOTOGINSENOSIDE R1 OR THEIR COMBINATION IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING DISEASES CAUSED BY MICROCIRCULATION DISORDER
    Publication number: 20120295858
    Abstract: The present invention relates to a new use of traditional Chinese drug products of Danshensu (DLA), Notoginsenoside R1 (R1) and their combination, in particular to the therapeutic and preventive effects of DLA, R1 and their combination on the diseases caused by microcirculation disorder.
    Type: Application
    Filed: November 4, 2010
    Publication date: November 22, 2012
    Inventors: Jingyan Han, Jun Guo, Jiying Yang, Kai Sun, Mingxia Wang, Yu Zhang, Yuying Liu
  • TRADITIONAL CHINESE DRUG COMPRISING DANSHEN EXTRACTS AND SANQI EXTRACTS AND USE THEREOF
    Publication number: 20120251634
    Abstract: The present invention discloses a traditional Chinese drug consisting of Danshen extract and Sanqi extract, the pharmaceutical composition comprising the above traditional Chinese drug as an active component and the use thereof. The traditional Chinese drug consists of Danshen extract and Sanqi extract in a weight ratio of (2˜6):(0.5˜2). The invention further discloses the effect of the above traditional Chinese drug and the pharmaceutical composition comprising the above traditional Chinese drug as an active component for treating cardiac microcirculation disorder and myocardial damage induced by ischemia/reperfusion.
    Type: Application
    Filed: December 17, 2010
    Publication date: October 4, 2012
    Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Jingyan Han, Jun Guo, Jiying Yang, Yu Zhang, Mingxia Wang, Yuying Liu